These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7651 related items for PubMed ID: 2438872

  • 1. Dopaquinone addition products in cultured human melanoma cells.
    Carstam R, Hansson C, Lindbladh C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1987; 67(2):100-5. PubMed ID: 2438872
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The effect of cysteine on oxidation of tyrosine, dopa, and cysteinyldopas.
    Agrup G, Hansson C, Rorsman H, Rosengren E.
    Arch Dermatol Res; 1982; 272(1-2):103-15. PubMed ID: 6819815
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of DOPA-loading on glutathione-dependent 5-S-cysteinyldopa genesis in melanoma cells in vitro.
    Mojamdar M, Ichihashi M, Mishima Y.
    J Invest Dermatol; 1982 Mar; 78(3):224-6. PubMed ID: 6799583
    [Abstract] [Full Text] [Related]

  • 7. gamma-Glutamyl transpeptidase, tyrosinase, and 5-S-cysteinyldopa production in melanoma cells.
    Mojamdar M, Ichihashi M, Mishima Y.
    J Invest Dermatol; 1983 Aug; 81(2):119-21. PubMed ID: 6135733
    [Abstract] [Full Text] [Related]

  • 8. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
    Morishima T, Tatsumi F, Fukada E, Saito M, Fujita M, Nagashima N, Hanawa S.
    Arch Dermatol Res; 1983 Aug; 275(2):76-9. PubMed ID: 6409012
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G, Hansson C, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1978 Aug; 58(3):270-2. PubMed ID: 78645
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intracellular distribution of dopa and 5-S-cysteinyldopa in pigment cells with minimal pigment formation.
    Agrup G, Hansson C, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1979 Aug; 59(4):355-6. PubMed ID: 92151
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1980 Aug; 60(5):399-402. PubMed ID: 6162310
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.
    Kågedal B, Gawelin AL, Pettersson A.
    Anal Biochem; 1987 Aug 15; 165(1):167-74. PubMed ID: 3120620
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of 5-S-cysteinyldopa formation by tyrosinase activity and intracellular thiols in human melanoma cells.
    Benathan M.
    Melanoma Res; 1996 Jun 15; 6(3):183-9. PubMed ID: 8819121
    [Abstract] [Full Text] [Related]

  • 20. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
    Agrup G, Falck B, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1977 Jun 15; 57(4):313-5. PubMed ID: 70922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 383.